{"product_id":"scl-vrio-analysis","title":"Stepan Company (SCL): VRIO Analysis [Mar-2026 Updated]","description":"\u003cbr\u003e\u003cp\u003eIs Stepan Company (SCL)'s success built on fleeting trends or truly sustainable competitive advantage? This VRIO analysis distills the core of its strategy, rigorously testing its key resources for Value, Rarity, Inimitability, and Organization. Dive in now to uncover the definitive verdict on what truly sets Stepan Company (SCL) apart - or leaves it vulnerable.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eStepan Company (SCL) - VRIO Analysis: 1. Leading Global Surfactant Manufacturing Scale\n\u003c\/h2\u003e\n\u003cp\u003eYou're looking at Stepan Company's scale in surfactants, which is the bedrock of their business, making up a huge chunk of their revenue - \u003cstrong\u003e57.3%\u003c\/strong\u003e in 2023, for instance. Honestly, this scale is what lets them compete with giants like BASF SE and Dow Inc. in the global market, which itself is estimated at \u003cstrong\u003e$48.01 billion\u003c\/strong\u003e in 2025.\u003c\/p\u003e\n\n\u003cp\u003eHere’s the quick math on how this scale stacks up against the VRIO framework, focusing on the operational reality we see in early 2025.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eVRIO Dimension\u003c\/td\u003e\n\u003ctd\u003eAssessment\u003c\/td\u003e\n\u003ctd\u003eSupporting Data\/Implication\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eHigh-volume production drives cost advantages for major consumer product customers. Q1 2025 Surfactant net sales hit \u003cstrong\u003e$430.3 million\u003c\/strong\u003e.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRarity\u003c\/td\u003e\n\u003ctd\u003eYes (Near Top Tier)\u003c\/td\u003e\n\u003ctd\u003eBeing one of the top five global surfactant producers is rare, though not unique in the broader chemical space.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImitability\u003c\/td\u003e\n\u003ctd\u003eDifficult\u003c\/td\u003e\n\u003ctd\u003eRequires massive capital outlay and time to build the necessary global manufacturing footprint and entrenched supply contracts.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrganization\u003c\/td\u003e\n\u003ctd\u003eYes\u003c\/td\u003e\n\u003ctd\u003eOperational efficiency is evident, demonstrated by achieving \u003cstrong\u003e$48.0 million\u003c\/strong\u003e in cost out savings in 2024. The new Pasadena, Texas facility is now operational to further this.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCompetitive Advantage\u003c\/td\u003e\n\u003ctd\u003eSustained\u003c\/td\u003e\n\u003ctd\u003eEconomies of scale in a critical input market, backed by strategic capacity expansion like the \u003cstrong\u003e25%\u003c\/strong\u003e increase in Alpha Olefin Sulfonates (AOS) production capacity in 2025.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue: Cost Advantage and Customer Service\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe sheer size of Stepan Company’s surfactant operations means they can produce inputs cheaper than smaller players. This is non-negotiable when you are a core supplier to the big names in home and personal care. For example, their Surfactants segment saw net sales increase by \u003cstrong\u003e10%\u003c\/strong\u003e in Q1 2025, supported by a \u003cstrong\u003e3%\u003c\/strong\u003e volume increase. This scale helps them absorb shocks, like the one-time costs they managed in 2024, which totaled \u003cstrong\u003e$48.0 million\u003c\/strong\u003e in savings.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity: Top-Five Status\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWhile many companies make surfactants, being recognized as one of the top five global manufacturers is rare. This top-tier status is built on decades of focused investment across 17 manufacturing sites in 12 countries. It’s not just about volume; it’s about the specific, hard-to-replicate global network that serves diverse end-markets like agriculture and oilfield, which saw double-digit volume growth in Q1 2025.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability: Capital and Relationships\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eReplicating this is tough because it’s a two-part barrier. First, the capital required for world-scale chemical plants is enormous. Second, and perhaps stickier, are the long-term supply agreements with major consumer goods companies. If onboarding takes 14+ days, churn risk rises, but established relationships are defintely harder to break. The recent startup of the Pasadena, Texas facility, which management expects to ramp up to over \u003cstrong\u003e60 products\u003c\/strong\u003e in the second half of 2025, is a massive capital commitment that competitors must match to keep pace.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization: Operational Excellence\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStepan Company is organized to extract maximum benefit from this scale. The \u003cstrong\u003e$48.0 million\u003c\/strong\u003e in cost savings achieved in 2024 shows a system capable of driving efficiency even while dealing with external issues like the Millsdale flood and a fraud event. Furthermore, the organization is clearly focused on strategic growth, evidenced by the Q1 2025 results showing a \u003cstrong\u003e32%\u003c\/strong\u003e year-over-year increase in adjusted net income, partly due to improved product mix and lower tax rates. They are set up to capitalize on their assets.\u003c\/p\u003e\n\u003cp\u003eFinance: draft 13-week cash view by Friday\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eStepan Company (SCL) - VRIO Analysis: 2. Diversified End-Market Exposure\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Insulates earnings from downturns in any single sector, balancing performance across cleaning, agriculture, and construction.\u003c\/p\u003e\n\u003cp\u003eThe value proposition is supported by the breadth of end-markets served:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAgriculture\u003c\/li\u003e\n\u003cli\u003eOilfield\u003c\/li\u003e\n\u003cli\u003eConstruction and Industrial Solutions\u003c\/li\u003e\n\u003cli\u003eConsumer (Detergents, Personal Care)\u003c\/li\u003e\n\u003cli\u003eIndustrial Cleaning\u003c\/li\u003e\n\u003cli\u003eFlavors and Food\u003c\/li\u003e\n\u003cli\u003ePharmaceuticals\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Common among large chemical firms, but Stepan's specific mix across 8+ industries is distinct. Stepan serves a wide array of industries, including:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDetergents, fabric softeners, hard surface cleaners\u003c\/li\u003e\n\u003cli\u003eShampoos, lotions, toothpastes, and cosmetics\u003c\/li\u003e\n\u003cli\u003eGermicidal quaternary compounds for hospitals and restaurants\u003c\/li\u003e\n\u003cli\u003eFoamers in gypsum wallboard\u003c\/li\u003e\n\u003cli\u003ePaints and coatings\u003c\/li\u003e\n\u003cli\u003eAgricultural products application\u003c\/li\u003e\n\u003cli\u003ePlasticizers, polyester and alkyd resins for construction and automotive\u003c\/li\u003e\n\u003cli\u003ePolyurethane polyols for laminate board, coatings, adhesives, sealants, and elastomers (CASE)\u003c\/li\u003e\n\u003cli\u003eNatural flavors for the beverage industry\u003c\/li\u003e\n\u003cli\u003eEsters, fats, and oils for food and pharmaceutical industry\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Competitors can diversify, but replicating Stepan's specific market penetration takes time.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e Managed through distinct segment reporting (Surfactants, Polymers, Specialty Products) to track performance. The company's total revenue for the fiscal year 2024 was \u003cstrong\u003e$2.18 Billion USD\u003c\/strong\u003e, with the Trailing Twelve Months (TTM) revenue as of September 30, 2025, reported at \u003cstrong\u003e$2.30 Billion USD\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eSegment\u003c\/td\u003e\n\u003ctd\u003eIllustrative Financial Metric\/Performance Note\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSurfactants\u003c\/td\u003e\n\u003ctd\u003eDouble-digit growth in Agricultural and Oilfield end markets noted in Q1 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePolymers\u003c\/td\u003e\n\u003ctd\u003eNet sales remained flat year-over-year at \u003cstrong\u003e$146.1 million\u003c\/strong\u003e in a reported quarter\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty Products\u003c\/td\u003e\n\u003ctd\u003eContributes to overall revenue base alongside Surfactants and Polymers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary, as market shifts can favor more concentrated players if diversification becomes too broad.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eStepan Company (SCL) - VRIO Analysis: 3. Proprietary Alkoxylation Technology \u0026amp; New Capacity\n\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e The new Pasadena, Texas, facility became operational in \u003cstrong\u003eearly April 2025\u003c\/strong\u003e. This state-of-the-art investment provides a flexible capacity of approximately \u003cstrong\u003e75,000 metric tons per year\u003c\/strong\u003e of alkoxylates. The initial investment was announced at \u003cstrong\u003e$220.0 million\u003c\/strong\u003e, with an estimated Capex of \u003cstrong\u003e$265MM\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnnual Capacity\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e75,000 metric tons\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInitial Investment Announced\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$220.0 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEstimated Capex\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$265MM\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOperational Date\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eEarly April 2025\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Alkoxylation Sites (Post-Pasadena)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eThree\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e The facility is equipped for both ethoxylation and propoxylation processes, offering a flexible, world-scale asset. The company has the largest installed Low 1,4-Dioxane production capacity for the North American Merchant Market due to this and other investments.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Competitors face high barriers to entry for building and commissioning similar new assets. The construction phase involved more than \u003cstrong\u003e2 million work hours\u003c\/strong\u003e. The primary contractor achieved a Total Recordable Injury Rate (TRIR) of \u003cstrong\u003e0.4\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e The company is focused on realizing the full benefit of this asset in \u003cstrong\u003e2026\u003c\/strong\u003e. Higher start-up costs related to the Pasadena facility impacted Surfactant adjusted EBITDA in Q3 2025. The site has hired more than \u003cstrong\u003e40 employees\u003c\/strong\u003e to support operations.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e The site is currently ramping up production, having made \u003cstrong\u003e41 different products\u003c\/strong\u003e to date (as of Q3 2025). The full contribution rate is expected in \u003cstrong\u003e2026\u003c\/strong\u003e, providing a near-term volume advantage during the ramp-up period.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eStepan Company (SCL) - VRIO Analysis: 4. 57-Year Dividend Growth Record\n\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue: Signals financial discipline, management confidence, and attracts long-term, income-focused investors.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe commitment is evidenced by the current forward annual dividend payout of \u003cstrong\u003e$1.58\u003c\/strong\u003e per share, equating to a forward dividend yield of \u003cstrong\u003e3.49%\u003c\/strong\u003e as of recent reports.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity: An unbroken streak of 57 consecutive years of dividend increases is exceptionally rare in any industry.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStepan Company (SCL) has increased its dividend for \u003cstrong\u003e57\u003c\/strong\u003e consecutive years, placing it among the elite group of only 55 stocks in the entire market with a dividend increase streak exceeding 50 years, classifying it as a Dividend King.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability: Cannot be imitated; it is a function of historical performance and commitment.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe historical commitment is quantified by sustained growth metrics:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAverage annual dividend increase over the past five years: \u003cstrong\u003e7.95%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAverage annual dividend increase over the past ten years: \u003cstrong\u003e7.82%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe most recent dividend declaration on October 29, 2025, was \u003cstrong\u003e$0.3950\u003c\/strong\u003e per share, an increase of \u003cstrong\u003e$0.01\u003c\/strong\u003e from the previous payment of \u003cstrong\u003e$0.3850\u003c\/strong\u003e per share.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization: Supported by a focus on accelerating free cash flow generation, despite Q2 2025 negative FCF of ($14.4 million).\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe organization's financial management supported the dividend growth through Q2 2025, even while facing working capital pressures:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFree Cash Flow (FCF) for Q2 2025 was negative \u003cstrong\u003e($14.4 million)\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThis negative FCF was attributed to inventory builds for anticipated tariffs and hurricane season stockpiling.\u003c\/li\u003e\n\u003cli\u003eCash from Operations for Q2 2025 was \u003cstrong\u003e$11.2 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eCapital expenditures for Q2 2025 were \u003cstrong\u003e$25.6 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eManagement expressed optimism in delivering positive FCF for the full year 2025.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe current dividend payout structure relative to recent performance is:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003eSource Context\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnnual Dividend (FWD)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.58\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAnnual Payout\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrailing Twelve Month Payout Ratio (Earnings)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e79.80%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBased on trailing year of earnings\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFree Cash Flow Payout Ratio\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e22.16%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eBased on cash flow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5-Year Dividend CAGR\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e7.95%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAverage annual increase in the past 5 years\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarket Capitalization\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1,003,019,600\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eMarket Cap\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eP\/E Ratio\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e17.46\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePE ratio\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage: Sustained, as this history builds significant reputational capital with the investment community.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe sustained streak of \u003cstrong\u003e57\u003c\/strong\u003e years of dividend increases solidifies the company's reputation as a reliable shareholder returner, supported by a market capitalization of \u003cstrong\u003e$1,003,019,600\u003c\/strong\u003e and a P\/E ratio of \u003cstrong\u003e17.46\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eStepan Company (SCL) - VRIO Analysis: 5. ISCC PLUS Certified European Operations\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eMeets the rising demand for verifiable, sustainable, and bio-based chemical solutions in key regulatory markets, aligning with European regulatory trends such as the Corporate Sustainability Reporting Directive (CSRD).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRarity\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eFull certification across all European sites is a differentiator in the specialty chemical sector.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eImitability\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eRequires significant investment in process auditing and supply chain documentation, which is costly.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eAligns with the strategic emphasis on green chemistry and customer-centric innovation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eTemporary, as competitors are rapidly pursuing similar certifications, but Stepan has a head start.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric Category\u003c\/th\u003e\n\u003cth\u003eFinancial\/Statistical Data Point\u003c\/th\u003e\n\u003cth\u003eAmount\/Value\u003c\/th\u003e\n\u003cth\u003ePeriod\/Context\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eOverall Financial Scale\u003c\/td\u003e\n\u003ctd\u003eLatest Twelve Months (TTM) Revenue\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$2.304 Billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTTM\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOverall Financial Scale\u003c\/td\u003e\n\u003ctd\u003eFiscal Year 2024 Revenue\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$2.18 Billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFY 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProfitability Context\u003c\/td\u003e\n\u003ctd\u003eFiscal Year 2024 Adjusted EBITDA\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$187.0 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFY 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecent Performance\u003c\/td\u003e\n\u003ctd\u003eFirst Quarter 2025 Net Income\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$19.7 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ1 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSustainability Alignment\u003c\/td\u003e\n\u003ctd\u003eReported Compliance Focus\u003c\/td\u003e\n\u003ctd\u003eTracking regulatory requirements for \u003cstrong\u003eCSRD\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003e2024 Reporting Period\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe company's commitment is part of a broader strategy, evidenced by:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eReported Scope 1 and 2 greenhouse gas emissions data assurance for 2024.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSetting new 2030 Environmental Goals.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eStepan Company (SCL) - VRIO Analysis: 6. Strong Presence in High-Growth Ag\/Oilfield Markets\n\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e These segments drove double-digit volume growth in Surfactants during Q1 and Q2 2025, offsetting softer consumer demand.\u003c\/p\u003e\n\u003cp\u003eFor the Three Months Ended March 31, 2025 (Q1 2025), Surfactant sales volume was up 3% year-over-year, primarily due to double-digit growth within the Agricultural and Oilfield end markets. Surfactant net sales reached $430.3 million, a 10% increase versus the prior year. For the Second Quarter 2025 (Q2 2025), the company continued to experience double-digit volume growth within the Agricultural and Oilfield end markets, which partially offset a 1% year-over-year decline in overall Surfactants sales volume. Surfactant net sales for Q2 2025 were $411.5 million, an 8% increase versus the prior year.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eQ1 2025\u003c\/th\u003e\n\u003cth\u003eQ2 2025\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSurfactants Net Sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$430.3 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$411.5 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSurfactants Net Sales YoY Change\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e10%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e8%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAg\/Oilfield Volume Growth\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eDouble-digit\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eDouble-digit\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOverall Surfactants Volume Change\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e3%\u003c\/strong\u003e increase\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e1%\u003c\/strong\u003e decrease\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e The specific customer relationships and product formulations for these demanding applications are not easily replicated.\u003c\/p\u003e\n\u003cp\u003eThe strength in these areas contributed to Surfactant Adjusted EBITDA growth of 10% in Q1 2025. In Q2 2025, Surfactant Adjusted EBITDA was similar to the prior year, despite a 1% decline in sales volume.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Requires deep application knowledge and long qualification cycles with end-users.\u003c\/p\u003e\n\u003cp\u003eThe focus on Tier two and Tier three customers, alongside growth in Ag\/Oilfield, was noted to deliver positive price mix in Q1 2025.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e The commercial team is actively developing new business, showing alignment with this growth vector.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFor Q1 2025, the company added over 400 new customers within the Surfactant business.\u003c\/li\u003e\n\u003cli\u003eThe new Pasadena, Texas site, supporting specialty alkoxylation growth, became operational in Q1 2025.\u003c\/li\u003e\n\u003cli\u003ePre-tax earnings in Q2 2025 were negatively impacted by $6.1 million due to start-up costs associated with the new Pasadena, Texas alkoxylation site.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained, provided Stepan continues to innovate faster than rivals in these specialized areas.\u003c\/p\u003e\n\u003cp\u003eThe double-digit growth in Ag\/Oilfield in Q1 2025 was noted as a key strategic end market. In Q2 2025, this growth was explicitly mentioned as offsetting lower demand in the global commodity Consumer Products end market.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eStepan Company (SCL) - VRIO Analysis: 7. Global Manufacturing Footprint (17 Sites\/12 Countries)\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Enables localized supply, reduces transportation risk, and allows for regional product tailoring.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e A broad, established global footprint is a significant barrier to entry for new large-scale competitors.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Extremely high due to the massive capital, permitting, and time required to build out this network. Capital expenditures for the full year 2024 were $122.8 million, and the forecast for 2025 capital expenditures is $120-125 million.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e The company manages this complexity, though it presents challenges in managing localized competitive pressures. The company utilizes a network of modern production facilities with approximately 2,015 to 2,396 employees across its operations.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained, as it is deeply embedded in the physical infrastructure of the business.\u003c\/p\u003e\n\u003cp\u003eThe global manufacturing network includes the following known locations:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegion\u003c\/td\u003e\n\u003ctd\u003eCountry\u003c\/td\u003e\n\u003ctd\u003eSite Location\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNorth America\u003c\/td\u003e\n\u003ctd\u003eUnited States\u003c\/td\u003e\n\u003ctd\u003eAnaheim, California\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNorth America\u003c\/td\u003e\n\u003ctd\u003eUnited States\u003c\/td\u003e\n\u003ctd\u003eColumbus, Georgia\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNorth America\u003c\/td\u003e\n\u003ctd\u003eUnited States\u003c\/td\u003e\n\u003ctd\u003eFieldsboro, New Jersey\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNorth America\u003c\/td\u003e\n\u003ctd\u003eUnited States\u003c\/td\u003e\n\u003ctd\u003eMaywood, New Jersey\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNorth America\u003c\/td\u003e\n\u003ctd\u003eUnited States\u003c\/td\u003e\n\u003ctd\u003eMillsdale (Joliet), Illinois\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNorth America\u003c\/td\u003e\n\u003ctd\u003eUnited States\u003c\/td\u003e\n\u003ctd\u003eWinder, Georgia\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNorth America\u003c\/td\u003e\n\u003ctd\u003eMexico\u003c\/td\u003e\n\u003ctd\u003eEcatepec\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNorth America\u003c\/td\u003e\n\u003ctd\u003eMexico\u003c\/td\u003e\n\u003ctd\u003eMatamoros\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSouth America\u003c\/td\u003e\n\u003ctd\u003eColombia\u003c\/td\u003e\n\u003ctd\u003eManizales\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSouth America\u003c\/td\u003e\n\u003ctd\u003eBrazil\u003c\/td\u003e\n\u003ctd\u003eSalto\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSouth America\u003c\/td\u003e\n\u003ctd\u003eBrazil\u003c\/td\u003e\n\u003ctd\u003eVespasiano\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEurope\u003c\/td\u003e\n\u003ctd\u003ePoland\u003c\/td\u003e\n\u003ctd\u003eBrzeg Dolny\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEurope\u003c\/td\u003e\n\u003ctd\u003eUnited Kingdom\u003c\/td\u003e\n\u003ctd\u003eStalybridge\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEurope\u003c\/td\u003e\n\u003ctd\u003eGermany\u003c\/td\u003e\n\u003ctd\u003eWesseling (Cologne)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEurope\u003c\/td\u003e\n\u003ctd\u003eFrance\u003c\/td\u003e\n\u003ctd\u003eVoreppe (Grenoble)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAsia\u003c\/td\u003e\n\u003ctd\u003ePeople's Republic of China\u003c\/td\u003e\n\u003ctd\u003eNanjing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAsia\u003c\/td\u003e\n\u003ctd\u003eSingapore\u003c\/td\u003e\n\u003ctd\u003eJurong Island\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe footprint optimization strategy has included recent transactions:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSale of manufacturing assets in Bauan, Batangas, Philippines.\u003c\/li\u003e\n\u003cli\u003eAgreement to sell manufacturing assets in Lake Providence, Louisiana (expected to close before the end of 2025).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe company's global sales volume was up 1% year-over-year for the full year 2024. Full Year 2024 Revenue was $2.2 B.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eStepan Company (SCL) - VRIO Analysis: 8. Cost Management \u0026amp; Operational Excellence Culture\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Directly impacts profitability, as seen by the \u003cstrong\u003e$\\$48.0$ million\u003c\/strong\u003e in cost out savings achieved in 2024, boosting 2024 Reported Net Income by \u003cstrong\u003e$25\\%$\u003c\/strong\u003e YoY to \u003cstrong\u003e$\\$50.4$ million\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e While all companies aim for it, Stepan's demonstrated ability to execute cost reduction is a tangible asset, achieving \u003cstrong\u003e$\\$48.0$ million\u003c\/strong\u003e in savings against a \u003cstrong\u003e$\\$50$ million\u003c\/strong\u003e goal for 2024.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Processes can be copied, but the ingrained culture driving consistent execution is hard to replicate.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e A core focus, as management emphasized cost reduction as a strategic priority, delivering \u003cstrong\u003e$\\$13.0$ million\u003c\/strong\u003e in pre-tax savings in the fourth quarter of 2024 alone.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary, as operational efficiency is a constant competitive battleground, but strong execution yields short-term gains.\u003c\/p\u003e\n\u003cp\u003eKey Financial Metrics Related to Operational Excellence (Full Year 2024):\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eAmount (USD)\u003c\/th\u003e\n\u003cth\u003eComparison\/Context\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCost Out Savings Achieved\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$\\$48.0$ million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDelivered in 2024.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReported Net Income (YTD)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$\\$50.4$ million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUp \u003cstrong\u003e$25\\%$\u003c\/strong\u003e versus prior year.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdjusted EBITDA (YTD)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$\\$187.0$ million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUp \u003cstrong\u003e$4\\%$\u003c\/strong\u003e year-over-year.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFree Cash Flow (YTD)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$\\$39.3$ million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUp from negative \u003cstrong\u003e$\\$85.5$ million\u003c\/strong\u003e in the prior year.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe execution of cost management is integrated into the company's operational framework, evidenced by:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eRecognizing \u003cstrong\u003e$\\$18$ million\u003c\/strong\u003e in pre-tax savings in the first quarter of 2024 alone.\u003c\/li\u003e\n\u003cli\u003eDelivering \u003cstrong\u003e$\\$13.0$ million\u003c\/strong\u003e in pre-tax cost out savings in the fourth quarter of 2024.\u003c\/li\u003e\n\u003cli\u003eThe strategic priority of 'Cost \u0026amp; Operational Excellence' which includes Safe and Efficient Manufacturing, Asset Reliability, Cost Reduction, and Productivity Gains.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eStepan Company (SCL) - VRIO Analysis: 9. Specialty Products (MCT) Growth Trajectory\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e The Medium Chain Triglycerides (MCT) product line saw volume growth of \u003cstrong\u003e49%\u003c\/strong\u003e in Q2 2025, driving Specialty Product Adjusted EBITDA up \u003cstrong\u003e21%\u003c\/strong\u003e in Q1 2025. Specialty Products net sales for Q2 2025 were \u003cstrong\u003e$20.5 million\u003c\/strong\u003e, a \u003cstrong\u003e22%\u003c\/strong\u003e increase versus the prior year.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Strong, high-double-digit growth in a specific, higher-margin niche is a rare bright spot in a mixed quarter. The \u003cstrong\u003e49%\u003c\/strong\u003e MCT volume increase in Q2 2025 contrasts with a \u003cstrong\u003e1%\u003c\/strong\u003e overall global sales volume growth for the company in the same quarter.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Success is tied to proprietary processes and strong positioning in the dietary supplement\/food markets. The company is focused on new customer acquisition, reporting over \u003cstrong\u003e400\u003c\/strong\u003e new customers added in the quarter.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e Management is clearly focused on accelerating this business, which contributes to better product mix. The company delivered double-digit adjusted EBITDA growth in the first half of 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary, but the current momentum provides a strong near-term earnings tailwind. The company reported Q2 2025 Adjusted EBITDA of \u003cstrong\u003e$51.4 million\u003c\/strong\u003e, up \u003cstrong\u003e8%\u003c\/strong\u003e year-over-year.\u003c\/p\u003e\n\u003cp\u003eKey financial and operational metrics for the Specialty Products segment and related company performance in Q2 2025:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003eContext\/Period\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMCT Volume Growth\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e49%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ2 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty Products Net Sales\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$20.5 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ2 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty Products Net Sales Growth\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e22%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eYear-over-Year Q2 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsolidated Adjusted EBITDA\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$51.4 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ2 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsolidated Adjusted Net Income\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$12 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ2 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWorking Capital\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$490 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ2 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFree Cash Flow\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e-$14.4 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQ2 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eManagement commentary highlights the strategic focus areas:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eProduction at the new Pasadena, Texas site is ramping up and should provide incremental benefits in the second half of the year, with full contribution targeted by Q4 2025.\u003c\/li\u003e\n\u003cli\u003eThe company paid \u003cstrong\u003e$8.7 million\u003c\/strong\u003e in dividends to shareholders during the second quarter of 2025.\u003c\/li\u003e\n\u003cli\u003eAdjusted Net Income of \u003cstrong\u003e$12 million\u003c\/strong\u003e in Q2 2025 was up \u003cstrong\u003e27%\u003c\/strong\u003e versus the prior year, driven by Polymers, Crop Productivity earnings, and a lower effective tax rate of \u003cstrong\u003e19.2%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eCash from Operations was \u003cstrong\u003e$11.2 million\u003c\/strong\u003e for the quarter.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFinance: Re-run the 13-week cash flow model incorporating the Q2 2025 working capital build of \u003cstrong\u003e$490 million\u003c\/strong\u003e and the expected Pasadena site benefits by Friday.\u003c\/p\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":45516248383637,"sku":"scl-vrio-analysis","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/scl-vrio-analysis.png?v=1740218204","url":"https:\/\/dcf-model.com\/fr\/products\/scl-vrio-analysis","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}